April 27, 2022
New medicines and devices under development live and die on the strength of their clinical data. An asset’s journey is...
Read article
September 21, 2021
Earlier this summer, we published a series of articles on the need to utilize weighting and prioritization tools in the...
Read article
August 18, 2021
During the design of a clinical trial, many biotechs want to substantially reduce the risk of a good new therapy being...
Read article
August 9, 2021
Recently we discussed examining clinical development through a Bayesian lens, in honor of Cytel co-founder Nitin Patel...
Read article
July 28, 2021
“We found an optimal design in hours that might have taken months to find using standard methods,” reflected Fabien...
Read article
July 22, 2021
Earlier this year, Cytel founder Cyrus Mehta observed that clinical trial design is often treated like an art rather...
Read article
July 14, 2021
For decades, statisticians have cultivated methods to optimize and de-risk clinical trials for strong regulatory...
Read article
July 7, 2021
Suppose a statistician were to tell a clinical trial sponsor that it was possible to improve the power of the sponsor’s...
Read article
June 23, 2021
Much of the discussion about clinical trial design considers methods to optimize performance characteristics and...
Read article
May 19, 2021
Clinical trial sponsors are more likely than ever to use the power of simulation and forecasting to evaluate the...
Read article
May 7, 2021
When is a study design considered to be optimal? A good design performs well not only under the ideal target scenario...
Read article
April 14, 2021
In the era of modern clinical development, several companies are turning towards novel and innovative approaches such...
Read article
March 18, 2021
Over the past ten years High-Performance Computing (HPC) has transformed medical research through advances in genomics,...
Read article
December 17, 2020
As Chief Scientific Officer, Dr. Yannis Jemiai plays a pivotal role in maintaining Cytel’s well-established reputation...
Read article
December 16, 2020
As we prepare to close the door on 2020, we asked Pantelis Vlachos, Principal/Strategic Consultant for Cytel, to share...
Read article
December 15, 2020
When designing clinical trials, biostatisticians and clinical development teams are often faced with a conundrum. Given...
Read article
December 9, 2020
As a part of Cytel’s Advanced Design Framework, a new Framework for the statistical design of clinical trials, Cytel...
Read article
December 3, 2020
Increasing Clinical Development Productivity Using Statistics and Cloud-Computing The need for Re-imagining Clinical...
Read article
November 18, 2020
The current state of the clinical trials industry faces a challenge that was only hypothetical three or four years ago....
Read article
November 11, 2020
The widespread use of cloud-computing has altered the clinical trial design process. Whereas three or four years ago,...
Read article
November 4, 2020
Cytel has recently revealed its Advanced Design Framework, a method developed by Cytel’s thought leaders that draws on...
Read article
October 29, 2020
Cytel has recently revealed its Advanced Design Framework, a method developed by Cytel’s thought leaders that draws on...
Read article
October 26, 2020
Pharmaceutical and biotech companies are under pressure to deliver more and deliver faster with fewer resources. The...
Read article
October 21, 2020
Cytel has recently revealed its Advanced Design Framework, a method developed by Cytel’s thought-leaders after a decade...
Read article
October 15, 2020
For over a decade, advanced trial design techniques have promised efficient trials with accelerated timelines,...
Read article
September 17, 2020
Keeping up with the rapid pace of clinical development means that we need to adopt the innovative or computationally...
Read article
August 31, 2020
Pantelis Vlachos, Principal, Strategic Consultant at Cytel, conducted a webinar to introduce the capabilities of East...
Read article
July 22, 2020
Cytel brings to you a new blog series on technology and Bayesian decision-making by Pantelis Vlachos,...
Read article
